1-3 of 3
Jochen Jochen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Siremadlin Monotherapy and in Combination with Donor Lymphocyte Infusion for Patients with Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation Who Are in Complete Remission but at High Risk for Relapse

Free
Robert Zeiser, Christoph Schmid, Gheath Alatrash, Ron Ram, Yuan Wu, Hans-Jochen Jochen Weber, Stephanie Grzesiak, Lamis K. Eldjerou, Charles Craddock
Journal: Blood
Blood (2022) 140 (Supplement 1): 8944–8945.
https://doi.org/10.1182/blood-2022-167011
Published: 2022
Journal Articles

Siremadlin (HDM201) Is Well Tolerated and Demonstrates Clinical Activity in Patients with Acute Myeloid Leukemia Who Have Relapsed after Allogeneic Stem Cell Transplantation: A Subset Analysis of Safety and Preliminary Efficacy

Free
Eytan M. Stein, Jörg Chromik, Cecilia Carpio, Rogier Mous, Jean-Jacques Kiladjian, Gheath Alatrash, Antonio Curti, Charles Craddock, Christoph Schmid, Robert Zeiser, Lamis K. Eldjerou, Hans-Jochen Jochen Weber, Claire Fabre, Jeffrey Scott, Daniel J. DeAngelo
Journal: Blood
Blood (2021) 138 (Supplement 1): 3417.
https://doi.org/10.1182/blood-2021-149751
Published: 2021
Journal Articles

RHAMM/CD168-R3 Peptide Vaccination of Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Multiple Myeloma (MM) Elicits Immunological and Clinical Responses.

Free
Michael Schmitt, PhD, Anita Schmitt, MD, Krzysztof Giannopoulos, MD, Li Li, PhD, Peter Liebisch, MD, Jinfei Chen, MD, Mark Ringhoffer, MD, Phillipe Guillaume, PhD, Gerd Ritter, PhD, Markus Rojewski, PhD, Sascha Gnjatic, PhD, Hartmut Dohner, MD, Jochen Jochen, MD
Journal: Blood
Blood (2006) 108 (11): 409.
https://doi.org/10.1182/blood.V108.11.409.409
Published: 2006